上海博升生物科技有限公司
- 联系人 :
- 地址 : 上海市肇嘉浜路825号尚秀商务楼2号楼5楼K座
- 邮编 : 200032
- 所在区域 : 上海
- 电话 : 空
- 传真 : 021-64280007
- 邮箱 : order@biosun.cn
| rHIV-I-int | HIV- 122 | Recombinant HIV-I pol Integrase |
| rHIV-Ip24gag | HIV- 123 | Recombinant HIV-I gag p24 77-436 a.a. , 39kDa |
| rHIV-Inef | HIV- 124 | Recombinant HIV-I nef 3-190 a.a. , 20kDa |
| rHIV-Igp160LAV | HIV- 125 | Recombinant HIV-I gp160 LAV |
| rHIV-Igp160MN | HIV- 126 | Recombinant HIV-I gp160 MN |
| rHIVp66pol | HIV- 127 | Recombinant HIV-I p66 pol |
| rHIV-ITAT | HIV- 129 | Recombinant HIV-I TAT |
| rHIV-Ip55gag | HIV- 130 | Recombinant HIV-I p55 gag |
| rHIV-I,II | HIV- 131 | Recombinant HIV-I Envelope conjugated to a gp39 HIV-II |
| rHIVOe | HIV- 132 | Recombinant HIV Type O Envelope |
| rHIVOgp41 | HIV- 133 | Recombinant HIV Type O gp41 |
| rHIV-IIgp32 | HIV- 134 | Recombinant HIV-II gp32 |
| rHIV-IIgp32-biotin | HIV- 135 | Recombinant HIV-II gp32, biotin conjugate |
| rHIV-IIgp32-hrp | HIV- 137 | Recombinant HIV-II gp32, Horseradish peroxidase labled |
| rHIV-IIgp36 | HIV- 138 | Recombinant HIV-II gp36 |
| rHIV-IIgp36-34kDa | HIV- 139 | Recombinant HIV-II gp36 (390-702 a.a), 34kDa |
| rHIV-II | HIV- 140 | Recombinant HIV-II Envelope |
| rSIVp55 | SIV- 114 | Recombinant SIV p55 |
| rHTLV-I | HIV- 107 | Recombinant HTLV-I Envelope |
| rHTLV-Ip24c | HIV- 108 | Recombinant HTLV-I p24 Core |
| rHTLV-Igp21 | HIV- 141 | Recombinant HTLV-I gp21 (351-404aa) |
| rHTLV-Igp46 | HIV- 142 | Recombinant HTLV-I gp46 (162-214/242-257aa) |
| rHTLV-Im | HIV- 144 | Recombinant HTLV-I Mosaic (374-400/190-207a.a.) |
| rHTLV-I+II | HIV- 115 | Recombinant HTLV-I+II |
| rEBV(HHV-4)M | EBV- 271 | Recombinant Epstein-Barr Virus (HHV-4) Mosaic EBNA1(1-90, 408-498 a.a.) |
| rEBV(HHV-4)EA | EBV- 272 | Recombinant Epstein-Barr Virus (HHV-4) EA (306-390a.a.) |
| rEBV(HHV-4)p18 | EBV- 273 | Recombinant Epstein-Barr Virus (HHV-4) p18 (1-119 a.a.) |
| rEBV(HHV-4)Mp18 | EBV- 275 | Recombinant Epstein-Barr Virus (HHV-4) Mosaic p18 |
| rEBV(HHV-4)p23 | EBV- 274 | Recombinant Epstein-Barr Virus (HHV-4) p23 (1-162 a.a.) |
| rTBEVgE | TBE- 281 | Recombinant Tick-Born Encephalitis Virus gE (95-229 a.a.) |
| rTBENE | TBE- 282 | Recombinant Tick-Born Encephalitis Virus NE/gE |
| rTBECE | TBE- 288 | Recombinant Tick-Born Encephalitis Virus CE/gE |
| rTBENEGECE | TBE- 289 | Recombinant Tick-Born Encephalitis Virus NE/GE/CE/gE |
| rTBEVgE-2 | TBE- 283 | Recombinant Tick-Born Encephalitis Virus gE middle (50-250 a.a.) |
| rTBEVgE-3 | TBE- 284 | Recombinant Tick-Born Encephalitis Virus gE C-end (296-414 a.a.) |
| rTBEJ | TBE- 290 | Recombinant Tick-Born Japanese Encephalitis Virus |
| rTBEVC | TBE- 285 | Recombinant Tick-Born Encephalitis Virus Core |
| rTBEVNS3 | TBE- 286 | Recombinant Tick-Born Encephalitis Virus NS3 |
| rTBEVpreM | TBE- 287 | Recombinant Tick-Born Encephalitis Virus preM |
| rMEVLP-58 | MEV-001 | Recombinant Measles Virus Large Polymerase (58-149 a.a.) |
| rMEVNSCP | MEV-002 | Recombinant Measles Virus Non-Structural C-Protein (1-51 a.a.) |
| rMEVLP-29 | MEV-003 | Recombinant Measles Virus Large Polymerase (2059-2183 a.a.) |
| rMEVN | MEV-004 | Recombinant Measles Virus Nucleocapsid (89-165 a.a) |
| rMEVHM1-30 | MEV-005 | Recombinant Measles Virus Hemagglutinin Mosaic (1-30/115-150/379-410aa) |
| rMEVFP | MEV-006 | Recombinant Measles Virus fusion protein (399-525 a.a) |
| rMEVHM1-106-114 | MEV-007 | Recombinant Measles Virus Hemagglutinin Mosaic (106-114/519-550a.a) |
| rRVE1M | RUB- 291 | Recombinant Rubella Virus E1 Mosaic (157-176, 374-390, 213-239a.a.) |
| rRVE2 | RUB- 292 | Recombinant Rubella Virus E2 (31-105 a.a.) |
| rRVCC | RUB- 293 | Recombinant Rubella Virus Capsid C (1-123a.a.) |
| rHA-Caledonia | IHA- 001 | Recombinant Hemagglutinin-Influenza A Virus H1N1 New Caledonia 20/99 |
| rHA-Texas | IHA- 008 | Recombinant Hemagglutinin-Influenza A Virus H1N1 Texas 36/91 |
| rHA-Netherlands | IHA- 009 | Recombinant Hemagglutinin-Influenza A Virus H7N7 Netherlands 219/03 |
| rNA-Beijing | IHA- 019 | Recombinant Neuraminidase H1N1 Beijing 262/95 |
| rHA-Vietnam | IHA- 010 | Recombinant Hemagglutinin-Influenza A Virus H5N1 Vietnam 1203/04 |
| rHA-Wyoming | IHA- 012 | Recombinant Hemagglutinin-Influenza A Virus H3N2 Wyoming 3/2003 |
| rHA-Wisconsin | IHA- 020 | Recombinant Hemagglutinin-Influenza A Virus H3N2 Wisconsin 67/05 |
| rHA-NY | IHA- 011 | Recombinant Hemagglutinin-Influenza A Virus H3N2 New York 55/04 |
| rHA-HongKong | IHA- 013 | Recombinant Hemagglutinin-Influenza A Virus H9N2 Hong Kong 1073/99 |
| rHB-HongKong | IHA- 014 | Recombinant Hemagglutinin-Influenza B Virus Hong Kong 330/2001 |
| rHB-Ohio | IHA- 015 | Recombinant Hemagglutinin-Influenza B Virus Ohio 01/05 |
| rHB-Jilin | IHA- 021 | Recombinant Hemagglutinin-Influenza B Virus Jilin 20/2003 |
| InfluQingdao | IHA- 016 | Influenza B Virus Qingdao/102/91 |
| InfluTokio | IHA- 017 | Influenza B Virus Tokio 53/99 |
| InfluVictoria | IHA- 018 | Influenza B Virus Victoria 504/00 |
| InfluBeijing | IHA- 002 | Influenza A Virus (H1N1) Beijing, 262/95 |
| InfluCaledonia | IHA- 003 | Influenza A Virus (H1N1) New Caledonia 20/99 IV 116 |
| InfluShandong | IHA- 004 | Influenza A Virus (H3N2) Shangdong 9/93 |
| InfluKiev | IHA- 005 | Influenza A Virus (H3N2) Kiev 301/94 like /Johannesburg/33/94 |
| InfluPanama | IHA- 006 | Influenza A Virus (H3N2) Panama 2007/99 |
| InfluTaiwan | IHA- 007 | Influenza A Virus (H1N1) Taiwan 1/86 |
| rHuCRYAA | HSP-002 | Recombinant Human Crystallin Alpha A |
| rHuCRYAB | HSP-003 | Recombinant Human Crystallin Alpha B |
| rDnak | HSP- 006 | Recombinant Dnak |
| rDnaJ | HSP- 007 | Recombinant DnaJ |
| rDnakSBD | HSP- 008 | Recombinant Dnak Substrate Binding Domain |
| rDnakSBD-Cterm | HSP- 009 | Recombinant Dnak Substrate Binding Domain C-terminal |
| rDnakATPaseBD | HSP- 010 | Recombinant Dnak ATPase Binding Domain |
| rDnakLCS | HSP- 011
|